Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Profit After Tax

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit After Tax ₹170 Cr₹442 Cr₹458 Cr₹642 Cr₹695 Cr

What is the latest Profit After Tax of NATCO PHARMA ?

The latest Profit After Tax ratio of NATCO PHARMA is ₹170 Cr based on Mar2023 Consolidated results.
Year Profit After Tax
Mar2023₹170 Cr
Mar2022₹442 Cr
Mar2021₹458 Cr
Mar2020₹642 Cr
Mar2019₹695 Cr

How is Profit After Tax of NATCO PHARMA Trending?

Years Profit After Tax % Change
Mar2023 ₹170 Cr
-61.57
Mar2022 ₹442 Cr
-3.43
Mar2021 ₹458 Cr
-28.69
Mar2020 ₹642 Cr
-7.59
Mar2019 ₹695 Cr -

Compare Profit After Tax of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,508.2 Cr 0.2% 6% 76% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.2%

6%

76%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses